Neuropace (NPCE): 10% owner sold ~$542K

~$542K

Approx. value · 34K sh @ $15.94

3.24M

Holds after · shares reported

Traded

May 14, 2025

Filed

May 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 14, 2025 · this disclosureInsider10% owner sold ~$542K of NPCE shares in the open market

What came next

1. May 14, 2025Insider10% owner sold ~$2.12M of NPCE shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuropace

For Neuropace, OQRO holds 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NPCE page.

Other recent filings by ORBIMED ADVISORS LLC, 10% owner

• SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
• SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
• SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
• SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
• SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026

The full history of ORBIMED ADVISORS LLC, 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Neuropace

• USAspending.gov award recordOct 5, 2026
• SEC Form 13F-HRAug 14, 2026
• USAspending.gov award recordJun 9, 2026
• SEC Form 13F-HRMay 15, 2026
• USAspending.gov award recordMar 17, 2026
• USAspending.gov award recordMar 11, 2026

Everything OQRO holds on this company is on its NPCE page.